Watchmaker Genomics Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
197
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$40M
- Investors
-
3
Watchmaker Genomics General Information
Description
Operator of a biotechnology company intended to offer breakthrough applications for reading, writing, and editing DNA. The company specializes in advanced enzymology to develop precision tools for life sciences, and its technology combines domain expertise in protein engineering with enzyme manufacturing to address the demanding quality, performanc,e and scale requirements of high-growth genomics applications, enabling clients to improve their experiment, assay, and workflow with scalable supply chain solutions that provide molecular-grade enzymes for a range of genomic applications.
Contact Information
Website
www.watchmakergenomics.comCorporate Office
- 5744 Central Avenue
- Suite 100
- Boulder, CO 80301
- United States
Corporate Office
- 5744 Central Avenue
- Suite 100
- Boulder, CO 80301
- United States
Watchmaker Genomics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series A) | 02-Jun-2022 | $40M | Completed | Generating Revenue | ||
| 2. Seed Round | 04-Dec-2020 | Completed | Generating Revenue | |||
| 1. Debt - PPP | 15-Apr-2020 | Completed | Generating Revenue |
Watchmaker Genomics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Seed-1 | ||||||||
| Seed | 4,549,938 | $0.000100 | $1.21 | $1.21 | 1x | $1.21 | 23% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Watchmaker Genomics Comparisons
Industry
Financing
Details
Watchmaker Genomics Competitors (57)
One of Watchmaker Genomics’s 57 competitors is CD Genomics, a Corporation company based in Shirley, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CD Genomics | Corporation | Shirley, NY | ||||
| Novogene | Formerly PE-Backed | Beijing, China | ||||
| ERS Genomics | Corporate Backed or Acquired | Dublin, Ireland | ||||
| Paragon Genomics | Venture Capital-Backed | Fremont, CA | ||||
| Standard BioTools | Formerly VC-backed | Boston, MA |
Watchmaker Genomics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Watchmaker Genomics Patents
Watchmaker Genomics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026187769-A1 | Kod polymerase variants with dihydrouracil tolerance | Pending | 04-Mar-2025 | ||
| AU-2026201615-A1 | Kod polymerase variants with uracil template tolerance | Pending | 04-Mar-2025 | ||
| US-20260347805-A1 | Kod polymerase variants with uracil template tolerance | Pending | 04-Mar-2025 | ||
| WO-2026187785-A1 | Kod polymerase variants with uracil template tolerance | Pending | 04-Mar-2025 | ||
| WO-2026148075-A1 | Multiplexed polynucleotide normalization | Pending | 30-Dec-2024 | C12Q1/6806 |
Watchmaker Genomics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Watchmaker Genomics Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Decheng Capital | Venture Capital | Minority | ||
| Eclipse Capital | Venture Capital | Minority | ||
| Life Science Angels | Angel Group | Minority |
Watchmaker Genomics FAQs
-
When was Watchmaker Genomics founded?
Watchmaker Genomics was founded in 2019.
-
Where is Watchmaker Genomics headquartered?
Watchmaker Genomics is headquartered in Boulder, CO.
-
What is the size of Watchmaker Genomics?
Watchmaker Genomics has 197 total employees.
-
What industry is Watchmaker Genomics in?
Watchmaker Genomics’s primary industry is Biotechnology.
-
Is Watchmaker Genomics a private or public company?
Watchmaker Genomics is a Private company.
-
What is the current valuation of Watchmaker Genomics?
The current valuation of Watchmaker Genomics is .
-
What is Watchmaker Genomics’s current revenue?
The current revenue for Watchmaker Genomics is .
-
How much funding has Watchmaker Genomics raised over time?
Watchmaker Genomics has raised $48.3M.
-
Who are Watchmaker Genomics’s investors?
Decheng Capital, Eclipse Capital, and Life Science Angels have invested in Watchmaker Genomics.
-
Who are Watchmaker Genomics’s competitors?
CD Genomics, Novogene, ERS Genomics, Paragon Genomics, and Standard BioTools are some of the 57 competitors of Watchmaker Genomics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
